Merrimack Pharmaceuticals Inc. (MACK) Climbed 5.12% or 0.54 To Price $10.99 On Wednesday


Merrimack Pharmaceuticals Inc. (MACK) climbed 5.12% or 0.54 to $10.99. It is near to 102129 shares traded, which is 73.41% compare to the average total volume 139116. The market cap of MACK is $146.53 million. The year to date change is -1.83%. The 52 week price range is from $10.04 to $39.9. Price of MACK have changed -0.43% during last week. It have changed -5.47% over last month, -10.64% over last 3 months, -18.95% over last 6 months and -67.02% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MACK is 10.75. It is -2.18% below current price. The 200-day Moving Averages for MACK is 13.99. It is 27.30% above current price. The 52-week High is 39.9. It is 263.06% from the current price. The 52-week Low is 10.04. It is -8.64% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of MACK is 11.4 on 2018-01-12. Short % to float is 38.72%. There are some statistics of MACK. It is has market cap $146.53 million. The share outstanding is 13.33 million. The average volume is 139116. The revenue is 61.24M. The gross profit is 57.92M. The percent of top 15 Institution holding is 42.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MACK is -722.72%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MACK is 281.49%.


Tags:

Share this post